Cárdenas, Javier
Kelepouris, Nicky
Adiga, Radhika
Yuen, Kevin C. J.
Funding for this research was provided by:
Novo Nordisk (NA)
Article History
Received: 20 June 2023
Accepted: 3 January 2024
First Online: 10 January 2024
Declarations
:
: The study was reviewed by the WCG Institutional Review Board and was determined to qualify for exempt status due to the anonymous nature of the survey. All methods were carried out in accordance with relevant guidelines and regulations. The surveys were conducted in accordance with the principles and guidelines established by the Office for Human Research Protections, the Insights Association Code of Standards and Ethics, and the Declaration of Helsinki. Respondents reviewed information about the purpose and nature of the survey. Respondents selected a yes/no option indicating informed consent to participate in the study prior to entering the screening portion of the survey. If they consented, they continued to the survey questions. Respondents could discontinue the survey at any time.
: Not applicable.
: Javier Cárdenas is a consultant for the National Football League. Kevin C.J. Yuen has received research grants to Barrow Neurological Institute from Crinetics, Ascendis, Corcept, and Amryt; served as an occasional advisory board member for Novo Nordisk, Ascendis, Corcept, Ipsen, Amryt, Crinetics, Recordati and Xeris; and served as an occasional speaker for Corcept, Novo Nordisk and Recordati. Nicky Kelepouris and Radhika Adiga are employed by, and own stock in, Novo Nordisk Inc., which sponsored this research.